Developer docs
API playgroundTry for free, no card

Search company profiles

MD Group

Full company profile

uuid00094wp

Namestring
MD Group
Legal namestring
MDE Services Group Limited
Websiteurl
mdgroup.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

MD Group (legally MDE Services Group Limited) is a UK-headquartered clinical trial services company founded in 2002 that provides patient-centric support services to pharmaceutical sponsors and Contract Research Organizations (CROs). The company delivers an integrated portfolio of services spanning patient travel and accommodation, decentralized clinical services (mobile health nursing and in-home procedures), patient payments and reimbursements, dedicated navigator coordination, clinical equipment logistics through its Horreum brand, and clinical research staffing through its Seacole Health brand. Its operations are organized across wholly-owned subsidiaries in the UK, US, Ireland, France, Netherlands, Singapore, Hong Kong, and Brazil, with active trial delivery reach extending into additional markets including Australia and India.

The company's underlying technology stack is anchored by the primarius digital platform—a patient mobile app, site portal, and client portal that digitally coordinates reimbursements, travel, and family support requests. This is complemented by Horreum's express medical supply distribution network for decentralized and hybrid trial logistics, and Seacole Health's flexible staffing platform for placing healthcare professionals into clinical research roles. The company reports a 99% patient satisfaction rate and holds FDA 21 CFR Part 11, EU GDPR, and GCP/ISO 9001-aligned compliance certifications.

MD Group generates revenue through contracted professional services and managed services engagements with enterprise pharma sponsors and CROs on a study-by-study basis. Its go-to-market is enterprise field sales, supplemented by event-driven business development at major industry conferences such as SCOPE Summit. Pricing is not publicly disclosed and is negotiated per project based on scope. The company's customer base includes biotech and pharmaceutical sponsors operating in rare disease, pediatric, cell and gene therapy, and increasingly diabetes/obesity therapeutic areas—with named clients including Rocket Pharmaceuticals and PTC Therapeutics. The business is founder-influenced, privately held, and has not disclosed external funding rounds.

Short descriptiontext

MD Group is a UK-headquartered clinical trial services firm that delivers patient support services—including travel, mobile health visits, payments, navigator coordination, logistics, and staffing—to pharmaceutical sponsors and CROs running decentralized and hybrid clinical trials globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBracknell, United Kingdom
HQ citystring
Bracknell
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, patient support services, decentralized clinical trials, patient travel logistics, clinical research staffing
Industry3 codes
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Health Services8000
Product category
Clinical Trial Patient Support Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Patient Support Services
TypeProfessional Services
Description

MD Group generates revenue by providing contracted patient support services to clinical trial sponsors and CROs, including patient travel, accommodation, mobile health visits, navigator coordination, and expense reimbursement management. Services are delivered on a project basis aligned with clinical trial protocols.

mdgroup.com
2Decentralized Clinical Services
TypeProfessional Services
Description

Revenue from delivering in-home clinical procedures, mobile nursing, and hybrid trial support services. Healthcare providers are dispatched to patient homes to conduct study-related activities, reducing the need for frequent site visits.

mdgroup.com
3Clinical Logistics and Equipment
TypeManaged Services
Description

Global clinical equipment logistics through Horreum, providing medical supply delivery to trial sites and patient homes, with express delivery services for decentralized trials.

mdgroup.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1primarius
Description

Patient mobile app that puts patients at the heart of clinical trials, offering expense claims, reimbursements, travel management, and family support requests.

mdgroup.com
+6 more records
Core offering1 text field

MD Group provides end-to-end patient support and decentralized clinical trial services to pharmaceutical sponsors and Contract Research Organizations (CROs). The company manages patient travel and accommodation, mobile health visits, patient payments and reimbursements, dedicated patient navigator coordination, global clinical equipment logistics, and clinical research staffing. Services are delivered on a contracted, study-by-study basis across multiple geographies including the UK, US, Europe, Asia-Pacific, and Latin America.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 99% patient satisfaction rate
+2 more records
Product overview1 text field

MD Group operates as a clinical trial services company offering an integrated ecosystem of patient-first solutions. The core service portfolio includes Patient Travel, Decentralized Clinical Services (Mobile Health), Patient Payments, Patient Coordination (Navigator Services), Clinical Logistics, and Clinical Staffing. These services are supported by digital platforms and sub-brands: primarius (a digital ecosystem with patient mobile app, site portal, and client portal for managing reimbursements, travel, and support requests), Seacole Health (a staffing agency for healthcare professionals), and Horreum (a medical supply chain and distribution service). The company combines these capabilities to deliver end-to-end clinical trial support that reduces patient burden and improves retention.

Product and service9 records
1Patient Travel Services
CategoryPatient Support Services
Description

Arranges and manages patient travel, accommodation, and relocation services to facilitate participation in clinical trials. Targeted at pharmaceutical sponsors and CROs running global clinical studies with patients requiring logistical support.

2Decentralized Clinical Services
CategoryMobile Health Services
Description

Provides in-home clinical procedures, mobile nursing, and remote patient monitoring to reduce the need for frequent site visits in decentralized and hybrid clinical trials. Designed for sponsors seeking to expand geographic reach and reduce site burden.

3Patient Payments
CategoryPatient Support Services
Description

Manages patient stipends, reimbursements, and financial support services throughout the clinical trial journey, including multi-country and multi-currency disbursements. Used by sponsors and CROs to reduce administrative burden on sites and improve patient participation.

4Patient Coordination (Navigator Services)
CategoryPatient Support Services
Description

Provides dedicated patient navigators to guide patients and families through the clinical trial process as single points of contact, offering personalized coordination across travel, payments, and clinical visits. Targeted at sponsors of complex trials in rare disease and pediatric populations.

5Clinical Logistics
CategoryClinical Supply Chain
Description

Offers global clinical equipment logistics including express delivery and supply chain management for decentralised and hybrid trials. Delivered via the Horreum medical distribution center with overnight or 2-3 day delivery depending on location.

6Seacole Health (Clinical Staffing Agency)
CategoryClinical Research Staffing
Description

A staffing agency placing healthcare professionals including phlebotomists, research coordinators, nurses, and doctors into clinical research roles. Provides flexible staffing for mobile health, on-site, and research roles to hospitals, CROs, and clinical trial sponsors.

7Horreum Medical Distribution
CategoryClinical Supply Chain
Description

Express medical supply delivery service to decentralized and hybrid clinical trials worldwide, with overnight or 2-3 day delivery depending on location. Mitigates supply chain issues for post-pandemic decentralized trial environments.

8primarius Digital Platform
CategoryDigital Platform
Description

A comprehensive digital ecosystem comprising a patient mobile app, site portal, and client portal that connects patients, sites, and clients. Enables expense claims, reimbursements, travel arrangements, and family support requests throughout clinical trial participation.

9On-Demand Patient Concierge Services
CategoryPatient Support Services
Description

Patient concierge and travel services designed to reduce the practical and logistical burden of trial participation, providing tailored support services on demand for clinical trial participants and their families.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

MD Group partnered with PTC Therapeutics, a global biopharmaceutical company, to host a breakout session at SCOPE Summit 2026 focused on improving study confidence through patient support services. The collaboration centered on demonstrating the impact of patient support services on clinical trial outcomes and sponsor confidence.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

MD Group partnered with Rocket Pharmaceuticals to support a Phase I/II clinical study investigating a gene therapy for pediatric patients with Leukocyte Adhesion Deficiency-I (LAD-I), a rare disease. MD Group provided global patient support including travel logistics, accommodation, and home health visits to enable patient participation across multiple countries including India.

3SCOPE Summit (Clinical Research Community)
Strategic tierMinorTypeGTM or Marketing Partner
Description

MD Group has been an active sponsor and exhibitor at SCOPE Summit annually (2022, 2023, 2026), using the conference to build relationships with sponsors and CROs, share thought leadership, and showcase case studies. SCOPE serves as a key marketing and business development channel.

mdgroup.com
4Seacole Health
Strategic tierCoreTypeOthers
Description

Seacole Health is an MD Group company launched in 2021 as a standalone staffing agency for healthcare and research professionals in clinical trials. Seacole provides flexible staffing solutions including phlebotomists, research coordinators, and mobile health nurses to MD Group's clinical trial operations, as well as to external clients like hospitals and CROs.

mdgroup.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A leading provider of global patient concierge and reimbursement services for clinical trials, with a strong presence in decentralized and hybrid trial support. Closely overlaps with MD Group's Patient Travel, Payments, and Navigator offerings.

TypeDirect peer
Description

Specializes in patient reimbursement, stipend management (ClinCard), and travel/financial workflow automation for clinical trials. Directly comparable to MD Group's Patient Payments and Travel services and a competitor in the same procurement decisions.

TypeBroad incumbent
Description

The world's largest CRO offers integrated DCT, home health, and patient engagement services across thousands of trials. Competes with MD Group in sponsors' vendor selections and increasingly offers bundled solutions that can substitute MD Group's scope.

TypeBroad incumbent
Description

Major global CRO with growing DCT and patient-centric service lines post-PRA merger. Competes with MD Group both directly (DCT enablement) and indirectly via end-to-end CRO bundle pressure on mid-sized specialty vendors.

TypeBroad incumbent
Description

Large clinical and commercial services provider with decentralized clinical trial capabilities and patient engagement offerings. Overlaps with MD Group's mobile health and patient navigation services as part of broader sponsor RFPs.

TypeEmerging player
Description

A DCT-focused technology and services provider enabling decentralized and hybrid trials via a virtual research site model. Overlaps with MD Group's decentralized service line but with greater emphasis on virtual site operations.

TypeEmerging player
Description

Provides an eCOA, eConsent, telehealth, and DCT enablement technology platform used by sponsors and CROs. Comparable to the primarius patient app and adjacent to MD Group's broader service layer.

TypeRegional player
Description

Mid-sized CRO with therapeutic focus areas including rare disease; offers patient recruitment and clinical management services. A mid-tier competitor to MD Group especially in North America and Europe for rare disease sponsors.

TypeEmerging player
Description

Patient recruitment and feasibility vendor for clinical trials, with particular focus on patient-centric recruitment funnels. Directly comparable to MD Group's patient recruitment and retention enablement services.

TypeEmerging player
Description

Decentralized clinical trial company providing mobile nursing, telemedicine, and remote data capture for sponsors running fully decentralized studies. Competes with MD Group's decentralized clinical services and mobile health nursing offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MD Group

Clinical Trial Patient Support Servicesmdgroup.com

MD Group is a UK-headquartered clinical trial services firm that delivers patient support services—including travel, mobile health visits, payments, navigator coordination, logistics, and staffing—to pharmaceutical sponsors and CROs running decentralized and hybrid clinical trials globally.

What MD Group does

MD Group (legally MDE Services Group Limited) is a UK-headquartered clinical trial services company founded in 2002 that provides patient-centric support services to pharmaceutical sponsors and Contract Research Organizations (CROs). The company delivers an integrated portfolio of services spanning patient travel and accommodation, decentralized clinical services (mobile health nursing and in-home procedures), patient payments and reimbursements, dedicated navigator coordination, clinical equipment logistics through its Horreum brand, and clinical research staffing through its Seacole Health brand. Its operations are organized across wholly-owned subsidiaries in the UK, US, Ireland, France, Netherlands, Singapore, Hong Kong, and Brazil, with active trial delivery reach extending into additional markets including Australia and India.

The company's underlying technology stack is anchored by the primarius digital platform—a patient mobile app, site portal, and client portal that digitally coordinates reimbursements, travel, and family support requests. This is complemented by Horreum's express medical supply distribution network for decentralized and hybrid trial logistics, and Seacole Health's flexible staffing platform for placing healthcare professionals into clinical research roles. The company reports a 99% patient satisfaction rate and holds FDA 21 CFR Part 11, EU GDPR, and GCP/ISO 9001-aligned compliance certifications.

MD Group generates revenue through contracted professional services and managed services engagements with enterprise pharma sponsors and CROs on a study-by-study basis. Its go-to-market is enterprise field sales, supplemented by event-driven business development at major industry conferences such as SCOPE Summit. Pricing is not publicly disclosed and is negotiated per project based on scope. The company's customer base includes biotech and pharmaceutical sponsors operating in rare disease, pediatric, cell and gene therapy, and increasingly diabetes/obesity therapeutic areas—with named clients including Rocket Pharmaceuticals and PTC Therapeutics. The business is founder-influenced, privately held, and has not disclosed external funding rounds.

MD Group firmographics

Firmographics
Name
MD Group
Legal name
MDE Services Group Limited
Website
https://mdgroup.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
101–250 employees
Short description
MD Group is a UK-headquartered clinical trial services firm that delivers patient support services—including travel, mobile health visits, payments, navigator coordination, logistics, and staffing—to pharmaceutical sponsors and CROs running decentralized and hybrid clinical trials globally.
Ownership category
akta.pro rank

MD Group industry classification

Industry
Product category
Clinical Trial Patient Support Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Home Health Care Services (8082), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

  • Clinical trial services
  • Patient support services
  • Decentralized clinical trials
  • Patient travel logistics
  • Clinical research staffing

Where MD Group is headquartered

Location

Headquarters

HQ city
Bracknell
HQ country
United Kingdom
HQ region
Europe

Offices5 records

Markets served

MD Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Patient Support Services: MD Group generates revenue by providing contracted patient support services to clinical trial sponsors and CROs, including patient travel, accommodation, mobile health visits, navigator coordination, and expense reimbursement management. Services are delivered on a project basis aligned with clinical trial protocols.
  2. Decentralized Clinical Services: Revenue from delivering in-home clinical procedures, mobile nursing, and hybrid trial support services. Healthcare providers are dispatched to patient homes to conduct study-related activities, reducing the need for frequent site visits.
  3. Clinical Logistics and Equipment: Global clinical equipment logistics through Horreum, providing medical supply delivery to trial sites and patient homes, with express delivery services for decentralized trials.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

MD Group product offering

Product offering

Core offering

MD Group provides end-to-end patient support and decentralized clinical trial services to pharmaceutical sponsors and Contract Research Organizations (CROs). The company manages patient travel and accommodation, mobile health visits, patient payments and reimbursements, dedicated patient navigator coordination, global clinical equipment logistics, and clinical research staffing. Services are delivered on a contracted, study-by-study basis across multiple geographies including the UK, US, Europe, Asia-Pacific, and Latin America.

Product overview

MD Group operates as a clinical trial services company offering an integrated ecosystem of patient-first solutions. The core service portfolio includes Patient Travel, Decentralized Clinical Services (Mobile Health), Patient Payments, Patient Coordination (Navigator Services), Clinical Logistics, and Clinical Staffing. These services are supported by digital platforms and sub-brands: primarius (a digital ecosystem with patient mobile app, site portal, and client portal for managing reimbursements, travel, and support requests), Seacole Health (a staffing agency for healthcare professionals), and Horreum (a medical supply chain and distribution service). The company combines these capabilities to deliver end-to-end clinical trial support that reduces patient burden and improves retention.

Differentiator

Problem solved

Functional benefit

Brands

  • primarius: Patient mobile app that puts patients at the heart of clinical trials, offering expense claims, reimbursements, travel management, and family support requests.
  • Seacole Health
  • Horreum
  • mdgroup forest
  • mdgroup live
  • mdtalk
  • mdeducational foundation

Products and services

  • Patient Travel Services Arranges and manages patient travel, accommodation, and relocation services to facilitate participation in clinical trials. Targeted at pharmaceutical sponsors and CROs running global clinical studies with patients requiring logistical support.
  • Decentralized Clinical Services Provides in-home clinical procedures, mobile nursing, and remote patient monitoring to reduce the need for frequent site visits in decentralized and hybrid clinical trials. Designed for sponsors seeking to expand geographic reach and reduce site burden.
  • Patient Payments Manages patient stipends, reimbursements, and financial support services throughout the clinical trial journey, including multi-country and multi-currency disbursements. Used by sponsors and CROs to reduce administrative burden on sites and improve patient participation.
  • Patient Coordination (Navigator Services) Provides dedicated patient navigators to guide patients and families through the clinical trial process as single points of contact, offering personalized coordination across travel, payments, and clinical visits. Targeted at sponsors of complex trials in rare disease and pediatric populations.
  • Clinical Logistics Offers global clinical equipment logistics including express delivery and supply chain management for decentralised and hybrid trials. Delivered via the Horreum medical distribution center with overnight or 2-3 day delivery depending on location.
  • Seacole Health (Clinical Staffing Agency) A staffing agency placing healthcare professionals including phlebotomists, research coordinators, nurses, and doctors into clinical research roles. Provides flexible staffing for mobile health, on-site, and research roles to hospitals, CROs, and clinical trial sponsors.
  • Horreum Medical Distribution Express medical supply delivery service to decentralized and hybrid clinical trials worldwide, with overnight or 2-3 day delivery depending on location. Mitigates supply chain issues for post-pandemic decentralized trial environments.
  • primarius Digital Platform A comprehensive digital ecosystem comprising a patient mobile app, site portal, and client portal that connects patients, sites, and clients. Enables expense claims, reimbursements, travel arrangements, and family support requests throughout clinical trial participation.
  • On-Demand Patient Concierge Services Patient concierge and travel services designed to reduce the practical and logistical burden of trial participation, providing tailored support services on demand for clinical trial participants and their families.

Quantifiable outcome

  • 99% patient satisfaction rate
  • +2 more outcomes

Companies that use MD Group

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

MD Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

MD Group partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • PTC TherapeuticscoreStrategic or Co-development Partner · 1 April 2026MD Group partnered with PTC Therapeutics, a global biopharmaceutical company, to host a breakout session at SCOPE Summit 2026 focused on improving study confidence through patient support services. The collaboration centered on demonstrating the impact of patient support services on clinical trial outcomes and sponsor confidence.
  • Rocket PharmaceuticalscoreStrategic or Co-development Partner · 1 January 2019MD Group partnered with Rocket Pharmaceuticals to support a Phase I/II clinical study investigating a gene therapy for pediatric patients with Leukocyte Adhesion Deficiency-I (LAD-I), a rare disease. MD Group provided global patient support including travel logistics, accommodation, and home health visits to enable patient participation across multiple countries including India.
  • SCOPE Summit (Clinical Research Community)minorGTM or Marketing PartnerMD Group has been an active sponsor and exhibitor at SCOPE Summit annually (2022, 2023, 2026), using the conference to build relationships with sponsors and CROs, share thought leadership, and showcase case studies. SCOPE serves as a key marketing and business development channel.
  • Seacole HealthcoreOthersSeacole Health is an MD Group company launched in 2021 as a standalone staffing agency for healthcare and research professionals in clinical trials. Seacole provides flexible staffing solutions including phlebotomists, research coordinators, and mobile health nurses to MD Group's clinical trial operations, as well as to external clients like hospitals and CROs.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

MD Group competitors and assessment

Company assessment

Direct peers

  • PCM Trials: A leading provider of global patient concierge and reimbursement services for clinical trials, with a strong presence in decentralized and hybrid trial support. Closely overlaps with MD Group's Patient Travel, Payments, and Navigator offerings.
  • Greenphire: Specializes in patient reimbursement, stipend management (ClinCard), and travel/financial workflow automation for clinical trials. Directly comparable to MD Group's Patient Payments and Travel services and a competitor in the same procurement decisions.

Broad incumbents

  • IQVIA (Decentralized & Patient Solutions): The world's largest CRO offers integrated DCT, home health, and patient engagement services across thousands of trials. Competes with MD Group in sponsors' vendor selections and increasingly offers bundled solutions that can substitute MD Group's scope.
  • ICON plc (including PRA Health): Major global CRO with growing DCT and patient-centric service lines post-PRA merger. Competes with MD Group both directly (DCT enablement) and indirectly via end-to-end CRO bundle pressure on mid-sized specialty vendors.
  • Syneos Health: Large clinical and commercial services provider with decentralized clinical trial capabilities and patient engagement offerings. Overlaps with MD Group's mobile health and patient navigation services as part of broader sponsor RFPs.

Emerging players

  • Curebase: A DCT-focused technology and services provider enabling decentralized and hybrid trials via a virtual research site model. Overlaps with MD Group's decentralized service line but with greater emphasis on virtual site operations.
  • Medable: Provides an eCOA, eConsent, telehealth, and DCT enablement technology platform used by sponsors and CROs. Comparable to the primarius patient app and adjacent to MD Group's broader service layer.
  • Clariness: Patient recruitment and feasibility vendor for clinical trials, with particular focus on patient-centric recruitment funnels. Directly comparable to MD Group's patient recruitment and retention enablement services.
  • Science 37: Decentralized clinical trial company providing mobile nursing, telemedicine, and remote data capture for sponsors running fully decentralized studies. Competes with MD Group's decentralized clinical services and mobile health nursing offerings.

Regional players

  • Clinipace Worldwide: Mid-sized CRO with therapeutic focus areas including rare disease; offers patient recruitment and clinical management services. A mid-tier competitor to MD Group especially in North America and Europe for rare disease sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

MD Group social profiles

Digital presence

MD Group compliance and trust

Trust signal

Compliance3 records

MD Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MD Group leadership team

Management profile

Number of profiles

Profiles8 records

MD Group subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

MD Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MD Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MD Group

What does MD Group do?

MD Group provides end-to-end patient support and decentralized clinical trial services to pharmaceutical sponsors and Contract Research Organizations (CROs). The company manages patient travel and accommodation, mobile health visits, patient payments and reimbursements, dedicated patient navigator coordination, global clinical equipment logistics, and clinical research staffing. Services are delivered on a contracted, study-by-study basis across multiple geographies including the UK, US, Europe, Asia-Pacific, and Latin America.

Is MD Group a public or private company?

MD Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MD Group founded?

MD Group was founded in 2002. It employs 101 to 250 people.

Where is MD Group based?

MD Group is headquartered in Bracknell, United Kingdom, in the Europe region.

How does MD Group make money?

Three revenue lines are on record. Patient Support Services are the primary driver. The others are decentralized Clinical Services and clinical Logistics and Equipment.

Who are MD Group's main competitors?

Direct peers on record are PCM Trials and Greenphire. Broad incumbents are IQVIA (Decentralized & Patient Solutions), ICON plc (including PRA Health) and Syneos Health. Emerging players are Curebase, Medable, Clariness and Science 37. Clinipace Worldwide is listed as a regional player.

Does MD Group have an API?

No public API is recorded for MD Group.

What industry is MD Group in?

MD Group's product category is Clinical Trial Patient Support Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MdgroupThe Power of Clinical Trial Management ServicesThe article outlines the critical role of comprehensive clinical trial management services in addressing the increasing complexity of global clinical research, covering areas such as patient recruitment, logistics, and regulatory compliance. It specifically highlights mdgroup as a provider offering end-to-end solutions including travel coordination, decentralized clinical services, and global logistics to enhance patient retention and operational efficiency.PR Newswiremdgroup launches third fully compliant medical distribution centre in Europemdgroup has opened its third Horreum medical distribution centre in Amsterdam, Netherlands, expanding its global clinical trial supply network across Europe. The facility integrates clinical trial supply procurement, storage, logistics, and delivery with specialist services including mobile health and healthcare professional recruitment to support hybrid and decentralised clinical trials. The Amsterdam hub completes mdgroup's global Horreum network, joining existing facilities in Durham, North Carolina, USA, and Bracknell, UK.PR NewswireThe Mobile Health/Central Lab Interface, an opportunity for DCT efficiencymdgroup and Q2 Solutions will present at a DTRA podcast on December 9, 2022, discussing how improving communication between mobile health providers and central laboratories can reduce inefficiencies in hybrid and decentralised clinical trials. The presenters argue that the lack of direct contact between these interdependent service providers forces sponsors to act as intermediaries, creating communication gaps and duplicated efforts that compromise trial efficiency and data quality. This event is part of DTRA's ongoing TGIF-DCT series providing stakeholders a platform to share DCT best practices.MdgroupThe Ultimate Guide To The Future Of Clinical ResearchA whitepaper from mdgroup outlines how decentralised clinical trials, mobile health, wearables and AI are reshaping trial design, recruitment and retention. It cites that up to 80% of trial delays stem from recruitment and retention, with enrolment failures costing $600,000 to $8 million daily, and only 13% of trials ultimately successful. The authors call for hybrid models, value-driven endpoints and customisable technology solutions.PR Newswiremdgroup recognised as one of the UK's fastest-growing private companiesmdgroup was shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking. The MedTech firm has seen 300% growth over four years, with a team based on almost every continent. Winners will be announced in early July.PR Newswiremdgroup recognised as one of the UK's fastest-growing private companiesmdgroup, a global MedTech and patient services company, has been shortlisted for the inaugural Sunday Times 100 ranking of the UK's fastest-growing private companies, having achieved 300% growth over the past four years. The company, which provides clinical trial support services to pharmaceutical and biotech sponsors, previously grew sales from £12.8 million in 2017 to £25.7 million in 2020 and was named in the 2021 Organic Growth 25 index. Winners of the Sunday Times 100 ranking will be announced in early July, with Barclays Private Bank as headline sponsor.PR Newswiremdgroup Growth sees New VP, Product Delivery, Investing for the Futuremdgroup appointed Mohamad Merhi as VP of Product Delivery, tasked with doubling its development team and recruiting top global talent. The company, known for quantum growth, is scaling its product roadmap, including the primarius3 platform, to support patients in clinical trials. Merhi is seeking technologists to grow the team and further disrupt the healthtech sector.PR NewswireMdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journeymdgroup launched Primarius3, an enterprise platform integrating sites, sponsors, healthcare practitioners, and patients across clinical trials. The system includes a patient mobile app and aims to reduce admin burden and dropout rates. Future updates will add home visit information, AI payment/reimbursement, and medical supply distribution.PR Newswiremdgroup Listed Among the UK's Fastest-Scaling Firms in Organic Growth 25 Indexmdgroup, a global medtech and patient health services company, has been named to Buzzacott's Organic Growth 25 (OG25) index, recognizing it as one of the UK's fastest-scaling businesses in 2021 based on its growth without significant external investment. The company grew sales from £12.8 million in 2017 to £25.7 million in 2020 and increased its workforce from 42 to 89 employees during the same period. mdgroup's CEO highlighted the company's substantial investment in research and development and its focus on patient-centered healthcare technology addressing challenges across the clinical trial journey.